Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

Survival and predictors of outcome amongst patients with decompensated liver disease in a non-liver transplant ICU. Pessimism is historical and unjustified.

Sadick V, Bowcock E, Lane S, Seppelt I.

Intern Med J. 2018 Oct 31. doi: 10.1111/imj.14151. [Epub ahead of print]

PMID:
30379403
2.

The comparative effects of 3% saline and 0.5M sodium lactate on cardiac function:a randomised, crossover study in volunteers.

Nalos M, Kholodniak E, Smith L, Orde S, Ting I, Slama M, Seppelt I, McLean AS, Huang S.

Crit Care Resusc. 2018 Jun;20(2):124-130.

PMID:
29852851
3.

Lung Recruitment and Positive End-Expiratory Pressure Titration in Patients With Acute Respiratory Distress Syndrome.

Morris IS, Lane AS, Seppelt I.

JAMA. 2018 Mar 6;319(9):933-934. doi: 10.1001/jama.2017.21844. No abstract available.

PMID:
29509860
4.

Sedation Intensity in the First 48 Hours of Mechanical Ventilation and 180-Day Mortality: A Multinational Prospective Longitudinal Cohort Study.

Shehabi Y, Bellomo R, Kadiman S, Ti LK, Howe B, Reade MC, Khoo TM, Alias A, Wong YL, Mukhopadhyay A, McArthur C, Seppelt I, Webb SA, Green M, Bailey MJ; Sedation Practice in Intensive Care Evaluation (SPICE) Study Investigators and the Australian and New Zealand Intensive Care Society Clinical Trials Group.

Crit Care Med. 2018 Jun;46(6):850-859. doi: 10.1097/CCM.0000000000003071.

PMID:
29498938
5.

The SPICE III study protocol and analysis plan: a randomised trial of early goaldirected sedation compared with standard care in mechanically ventilated patients.

Shehabi Y, Forbes AB, Arabi Y, Bass F, Bellomo R, Kadiman S, Howe BD, McArthur C, Reade MC, Seppelt I, Takala J, Webb S, Wise MP; The SPICE III study investigators ; The Australian and New Zealand Intensive Care Society Clinical Trials Group ; The Australian and New Zealand Intensive Care Research Centre .

Crit Care Resusc. 2017 Dec;19(4):318-326.

PMID:
29202258
6.

Maintenance fluid practices in paediatric intensive care units in Australia and New Zealand.

Bihari S, Gelbart B, Seppelt I, Thompson K, Watts N, Prakash S, Festa M, Bersten A; The George Institute for Global Health ; The Australian and New Zealand Intensive Care Society Clinical Trials Group .

Crit Care Resusc. 2017 Dec;19(4):310-317.

PMID:
29202257
7.

Exit block in the intensive care unit.

Anstey MH, Thompson K, Seppelt I.

Med J Aust. 2017 Aug 4;207(5):224. No abstract available.

PMID:
28987140
8.

A cross-sectional survey of Australian and New Zealand public opinion on methods totriage intensive care patients in an influenza pandemic.

Cheung W, Myburgh J, McGuinness S, Chalmers D, Parke R, Blyth F, Seppelt I, Parr M, Hooker C, Blackwell N, DeMonte S, Gandhi K, Kol M, Kerridge I, Nair P, Saunders NM, Saxena MK, Thanakrishnan G, Naganathan V; Influenza Pandemic ICU Triage 3 study investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group.

Crit Care Resusc. 2017 Sep;19(3):254-265.

PMID:
28866976
9.

Considerations for co-enrolment in randomised controlled effectiveness trials in critical care: the SPICE-8 co-enrolment guidelines.

Reade MC, Bass F, Howe B, Seppelt I, Shehabi Y.

Crit Care Resusc. 2017 Jun;19(2):110-114.

PMID:
28651505
10.

Using Clinically Accessible Tools to Measure Sound Levels and Sleep Disruption in the ICU: A Prospective Multicenter Observational Study.

Litton E, Elliott R, Thompson K, Watts N, Seppelt I, Webb SAR; ANZICS Clinical Trials Group and The George Institute for Global Health.

Crit Care Med. 2017 Jun;45(6):966-971. doi: 10.1097/CCM.0000000000002405.

PMID:
28362644
11.

The Australian and New Zealand Intensive Care Society Clinical Trials Group point prevalence program, 2009-2016.

Thompson K, Hammond N, Eastwood G, Festa M, Glass P, Rajbhandari D, Seppelt I, Taylor C, Watts N, Myburgh J; The Point Prevalence Program Management Committee ; The Australian and New Zealand Intensive Care Society Clinical Trials Group ; The George Institute for Global Health .

Crit Care Resusc. 2017 Mar;19(1):88-93.

PMID:
28215137
12.

Elderly patients are at high risk of night-time admission to the intensive care unit following a rapid response team call.

Sundararajan K, Flabouris A, Thompson C, Seppelt I; George Institute of Global Health and the Australian and New Zealand Intensive Care Society Clinical Trials Group Point Prevalence study Investigators.

Intern Med J. 2016 Dec;46(12):1440-1442. doi: 10.1111/imj.13281.

PMID:
27981774
13.

Major trauma mortality in rural and metropolitan NSW, 2009-2014: a retrospective analysis of trauma registry data.

Dinh MM, Curtis K, Mitchell RJ, Bein KJ, Balogh ZJ, Seppelt I, Deans C, Ivers R, Berendsen Russell S, Rigby O.

Med J Aust. 2016 Nov 7;205(9):403-407.

PMID:
27809736
14.

Problematic Dichotomization of Risk for Intensive Care Unit (ICU)-Acquired Invasive Candidiasis: Results Using a Risk-Predictive Model to Categorize 3 Levels of Risk From a Multicenter Prospective Cohort of Australian ICU Patients.

Playford EG, Lipman J, Jones M, Lau AF, Kabir M, Chen SC, Marriott DJ, Seppelt I, Gottlieb T, Cheung W, Iredell JR, McBryde ES, Sorrell TC.

Clin Infect Dis. 2016 Dec 1;63(11):1463-1469. Epub 2016 Sep 6.

PMID:
27601224
15.

Maintenance fluid practices in intensive care units in Australia and New Zealand.

Bihari S, Watts NR, Seppelt I, Thompson K, Myburgh A, Prakash S, Bersten A; George Institute for Global Health and the Australian and New Zealand Intensive Care Society Clinical Trials Group.

Crit Care Resusc. 2016 Jun;18(2):89-94.

PMID:
27242106
16.

Hospital overnight and evaluation of systems and timelines study: A point prevalence study of practice in Australia and New Zealand.

Sundararajan K, Flabouris A, Thompson C, Seppelt I; George Institute of Global Health; Australian and New Zealand Intensive Care Society Clinical Trials Group Point Prevalence Study Investigators.

Resuscitation. 2016 Mar;100:1-5. doi: 10.1016/j.resuscitation.2015.11.029. Epub 2015 Dec 31.

PMID:
26748146
17.

Resuscitation fluid use in Australian and New Zealand Intensive Care Units between 2007 and 2013.

Hammond NE, Taylor C, Saxena M, Liu B, Finfer S, Glass P, Seppelt I, Willenberg L, Myburgh J.

Intensive Care Med. 2015 Sep;41(9):1611-9. doi: 10.1007/s00134-015-3878-y. Epub 2015 Jun 3.

PMID:
26077073
18.

Infection control in times of Ebola: how well are we training the next generation of intensivists in Australia and New Zealand?

Haren Fv, Cohen J, McKee A, Mitchell I, Pinder M, Seppelt I.

Crit Care Resusc. 2015 Jun;17(2):65-6. No abstract available.

PMID:
26017121
19.

Candida colonization as a risk marker for invasive candidiasis in mixed medical-surgical intensive care units: development and evaluation of a simple, standard protocol.

Lau AF, Kabir M, Chen SC, Playford EG, Marriott DJ, Jones M, Lipman J, McBryde E, Gottlieb T, Cheung W, Seppelt I, Iredell J, Sorrell TC.

J Clin Microbiol. 2015 Apr;53(4):1324-30. doi: 10.1128/JCM.03239-14. Epub 2015 Feb 11.

20.

Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial.

Fowler RA, Mittmann N, Geerts WH, Heels-Ansdell D, Gould MK, Guyatt G, Krahn M, Finfer S, Pinto R, Chan B, Ormanidhi O, Arabi Y, Qushmaq I, Rocha MG, Dodek P, McIntyre L, Hall R, Ferguson ND, Mehta S, Marshall JC, Doig CJ, Muscedere J, Jacka MJ, Klinger JR, Vlahakis N, Orford N, Seppelt I, Skrobik YK, Sud S, Cade JF, Cooper J, Cook D; Canadian Critical Care Trials Group; Australia and New Zealand Intensive Care Society Clinical Trials Group.

Trials. 2014 Dec 20;15:502. doi: 10.1186/1745-6215-15-502.

Supplemental Content

Loading ...
Support Center